The neutrophil-to-lymphocyte ratio: A narrative review

ecancermedicalscience

Volumn 10, Issue , 2016, Pages

  Faria, Sara Socorro ^a   Fernandes, Paulo César ^b   Silva, Marcelo José Barbosa ^b   Lima, Vladmir C ^b   Fontes, Wagner ^c   Freitas, Ruffo ^d   Eterovic, Agda Karina ^e   Forget, Patrice ^f  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Breast cancer; Inflammation; Neutrophil to lymphocyte ratio; Prognosis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; HISTOLOGY; HUMAN; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; REVIEW;

EID: 85009250645     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2016.702     Document Type: Review

References (52)

1. Siegel R, Ma J and Zou Z et al (2014) Cancer statistics Ca Cancer J Clin 64 (1) 9-29 DOI: 10.3322/caac.21208 PMID: 24399786
2. Saadatmand S, Bretveld R and Siesling S et al (2015) Influence of tumor stage at breast cancer detection on survival in modern times: population based study in 173797 patients BMJ 351 h4901 DOI: 10.1136/bmj.h4901
3. Guthrie GJ, Charles KA and Roxburgh CS et al (2013) The systemic inflammation-based neutrophil lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 88(1) 218-30 DOI: 10.1016/j.critrevonc.2013.03.010 PMID: 23602134
4. McMillan, DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer Curr Opin Clin Nutr Metab Care 12 223-26 DOI: 10.1097/MCO.0b013e32832a7902 PMID: 19318937
5. Templeton AJ, Ace O and McNamara MG et al (2014) Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis Cancer Epidemiol Biomarkers Prev 23(7) 1204-12 DOI: 10.1158/1055-9965.EPI-14-0146 PMID: 24793958
6. Denkert C, Loibl S and Noske A et al (2010) Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer J Clin Oncol 28(1) 105-113 DOI: 10.1200/JCO.2009.23.7370
7. Choi WJ, Cleghorn MC and Jiang H et al (2015) Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer Ann Surg Oncol 22(Suppl 3) S603-13 DOI: 10.1245/s10434-015-4571-7 PMID: 25900206
8. Nishijima TF, Muss HB and Shachar SS et al (2015) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis Cancer Treat Rev 41(10) 971-8 DOI: 10.1016/j.ctrv.2015.10.003 PMID: 26481060
9. Sanjay P, de Figueiredo RS and Leaver H et al (2012) Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreatic duodenectomy for pancreatic ductal adenocarcinoma JOP 13(2) 199-204 PMID: 22406601
10. Mallappa S, Sinha A and Gupta S et al (2013) Preoperative neutrophil to lymphocyte ratio > 5 is a prognostic factor for recurrent colorectal cancer Colorectal Dis 15(3) 323-328 DOI: 10.1111/codi.12008
11. Cho H, Hur HW and Kim SW et al (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58(1) 15-23. DOI: 10.1007/s00262-008-0516-3
12. Gondo T, Nakashima J and Ohno Y et al (2012) Prognostic value of neutrophiltolymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy Urology 79(5) 1085-91 DOI: 10.1016/j.urology.2011.11.070 PMID: 22446338
13. An X, Ding PR and Li YH et al (2010) Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer Biomarkers 15(6) 516-22 DOI: 10.3109/1354750X.2010.491557 PMID: 20602543
14. Ohno Y, Nakashima J and Ohori M et al (2014) Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status Int J Clin Oncol 19(1) 139-45 DOI: 10.1007/s10147-012-0514-5
15. Forget P, Bentin C and Machiels JP et al (2014) Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery Br J Anaesth 113(1) 82-7 DOI: 10.1093/bja/aet464
16. Dirican A, Kucukzeybek BB and Alacacioglu A et al (2014) Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol 18 18
17. Jie C, Qiwen D and Yuqin P et al (2015) Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer FEBS Open Bio 5 502-07 DOI: 10.1016/j.fob.2015.05.003
18. Wolff AC, Hammond ME and Hicks DG, et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Arch Pathol Lab Med 138(2) 241-56 DOI: 10.5858/arpa.2013-0953-SA PMCID: 4086638
19. Cimino-Mathews A, Foote J and Emens L (2015) Immune targeting in breast cancer Cancer Network 29 375-85
20. Galdiero MR, Bonavita E and Barajon I et al (2013) Tumor associated macrophages and neutrophils in cancer Immunobiology 218(11) 1402-10 DOI: 10.1016/j.imbio.2013.06.003 PMID: 23891329
21. Balkwill FR and Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities Semin Cancer Biol 22 33-40 DOI: 10.1016/j.semcancer.2011.12.005 PMID: 22210179
22. Noh H, Eomm M and Han A (2013) Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients J Breast Cancer 16 55-9 DOI: 10.4048/jbc.2013.16.1.55 PMID: 23593082 PMCID: 3625770
23. Wculek SK and Malanchi I (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells Nature 528(7582) 413-7 DOI: 10.1038/nature16140 PMID: 26649828 PMCID: 4700594
24. Coffelt SB, Kersten K and Doornebal CW et al (2015) IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis Nature 522(7556) 345-348 DOI: 10.1038/nature14282 PMID: 25822788 PMCID: 4475637
25. Jablonska J, Leschner S and Westphal K et al (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model J Clin Investig 120 1151-64 DOI: 10.1172/JCI37223 PMID: 20237412 PMCID: 2846036
26. Mantovani A, Allavena P and Sica A et al (2008) Cancer-related inflammation Nature 454(7203) 436-44 DOI: 10.1038/nature07205 PMID: 18650914
27. Quail DF and Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis Nat Med 19(11) 1423-37 DOI: 10.1038/nm.3394 PMID: 24202395 PMCID: 3954707
28. Cao J, Zhu X and Zhao X et al (2016) Neutrophil-to-lymphocyte ratio predicts PSA response and prognosis in prostate cancer: a systematic review and meta-analysis Coleman WB, ed PLoS One 11(7) e0158770 DOI: 10.1371/journal.pone.0158770 PMID: 27368058 PMCID: 4930176
29. Chen J, Deng Q and Pan Y et al (2015) Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer FEBS Open Bio 5 502-7 DOI: 10.1016/j.fob.2015.05.003 PMID: 26137435 PMCID: 4483486
30. Azab B, Bhatt VR and Phookan J et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and longterm mortality in breast cancer patients Ann Surg Oncol 19(1) 217-24 DOI: 10.1245/s10434-011-1814-0
31. Krenn-Pilko S, Langsenlehner U and Thurner EM et al (2014) The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Br J Cancer 110 2524-30 DOI: 10.1038/bjc.2014.163 PMID: 24675383 PMCID: 4021515
32. Suppan C, Bjelic-Radisic V and La Garde M et al (2015) Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy BMC Cancer 15 1027 DOI: 10.1186/s12885-015-2005-3 PMID: 26715527 PMCID: 4696229
33. Koh CH, Bhoo-Pathy N and Ng KL et al (2015) Utility of pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer Br J Cancer 113(1) 150-8 DOI: 10.1038/bjc.2015.183 PMID: 26022929 PMCID: 4647546
34. Negrier S, Escudier B and Gomez F et al (2002) Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie Ann Oncol 13 1460-8 DOI: 10.1093/annonc/mdf257
35. Schmidt H, Suciu S and Punt CJA et al (2007) Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 biochemo therapy trial J Clin Oncol 25 1562-9 DOI: 10.1200/JCO.2006.09.0274 PMID: 17443000
36. Proctor MJ, McMillan DC and Morrison DS et al (2012) A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer Brit J of Cancer 107(4) 695-9 DOI: 10.1038/bjc.2012.292
37. Azab B, Shah N and Radbel J et al (2013) Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients Med Oncol 30(1) 432 DOI: 10.1007/s12032-012-0432-4 PMID: 23283648
38. Ulas A, Avci N and Kos T et al (2015) Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? J BUON 20(3) 714-22 PMID: 26214622
39. Sato H, Tsubosa Y and Kawano T (2012) Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer World J Surg 36 617-22 DOI: 10.1007/s00268-011-1411-1 PMID: 22223293
40. Pistelli M, De Lisa M and Ballatore Z et al (2015) Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients BMC Cancer 15 195 DOI: 10.1186/s12885-015-1204-2 PMID: 25884918 PMCID: 4428113
41. Bozkurt O, Karaca H and Berk V et al (2015) Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients J BUON 20(6) 1432-9
42. Wculek SK and Malanchi I (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells Nature 528 413-7 DOI: 10.1038/nature16140 PMID: 26649828 PMCID: 4700594
43. The Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours Nature 490 61-70 DOI: 10.1038/nature11412 PMID: 23000897 PMCID: 3465532
44. Malorni L, Shetty PB and Dc Angelis C et al (2012) Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up Breast Cancer Res Treat 136 795-804 DOI: 10.1007/s10549-012-2315-y PMID: 23124476 PMCID: 3513514
45. Asano Y, Kashiwagi S and Onoda N et al (2015) Predictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer Ann Surg Oncol 28
46. Jia W, Wu J and Jia H et al (2015) The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-tomonocyte ratio for predicting the long-term survival of triple-negative breast cancer patients PLoS One 10(11) e0143061 DOI: 10.1371/journal.pone.0143061 PMID: 26580962 PMCID: 4666347
47. Brown SD (2014) Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival Genome Res 24 743-50 DOI: 10.1101/gr.165985.113 PMID: 24782321 PMCID: 4009604
48. Galon J, Pagès F and Marincola FM et al (2012) Cancer classification using the immunoscore: a worldwide task force J Transl Med 10 205 DOI: 10.1186/1479-5876-10-205 PMID: 23034130 PMCID: 3554496
49. M de Pedro S, Baeza MT and Escudero T et al (2015) Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis Breast Cancer Res Treat 149(2) 525-36 DOI: 10.1007/s10549-015-3267-9
50. X Garcia-Albeniz and AT Chan (2011) Aspirin for the prevention of colorectal cancer Best Pract Res Clingastroenterol 25 461-72 DOI: 10.1016/j.bpg.2011.10.015
51. Forget P, Vandenhende J and Berliere M et al (2010) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis Anesth Analg 110(6) 1630-5 DOI: 10.1213/ANE.0b013e3181d2ad07 PMID: 20435950
52. Choi JE, Villarreal J and Lasala J et al (2015) Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study Cancer Med 4(6) 825-33 DOI: 10.1002/cam4.428 PMID: 25756351 PMCID: 4472205